TreeWAS – Variant ID: rs6507022

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N70.1 Chronic salpingitis and oophoritis	0.037	0.963	0.000
A08.4 Viral intestinal infection, unspecified	0.000	0.977	0.023
Z83.7 Family history of diseases of the digestive system	0.000	0.985	0.015
C18.6 Descending colon	0.000	0.986	0.014
L71.9 Rosacea, unspecified	0.012	0.988	0.000
J93.9 Pneumothorax, unspecified	0.000	0.990	0.010
N70 Salpingitis and oophoritis	0.010	0.990	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.991	0.009
Q61.3 Polycystic kidney, unspecified	0.000	0.991	0.009
L50.9 Urticaria, unspecified	0.000	0.992	0.008
Y40.9 Systemic antibiotic, unspecified	0.000	0.992	0.008
H53.9 Visual disturbance, unspecified	0.008	0.992	0.000
N85.8 Other specified noninflammatory disorders of uterus	0.008	0.992	0.000
L50 Urticaria	0.000	0.992	0.008
Y52 Agents primarily affecting the cardiovascular system	0.000	0.992	0.008
L71 Rosacea	0.008	0.992	0.000
L50.0 Allergic urticaria	0.000	0.992	0.008
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.992	0.008
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.992	0.008
Y40 Systemic antibiotics	0.000	0.992	0.008
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.992	0.008
Y40.3 Macrolides	0.000	0.992	0.008
N20.1 Calculus of ureter	0.000	0.992	0.008
L71.1 Rhinophyma	0.007	0.992	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.000	0.993	0.007
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.993	0.007
N70.9 Salpingitis and oophoritis, unspecified	0.007	0.993	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.993	0.007
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.000	0.993	0.007
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.993	0.007
Y54.4 Loop [high-ceiling] diuretics	0.000	0.993	0.007
Y40.1 Cefalosporins and other -lactam antibiotics	0.000	0.993	0.007
Y54.3 Benzothiadiazine derivatives	0.000	0.993	0.007
Z71.8 Other specified counselling	0.000	0.993	0.007
Y54.7 Agents affecting calcification	0.000	0.993	0.006
L50-L54 Urticaria and erythema	0.000	0.993	0.007
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.993	0.006
Y40.5 Aminoglycosides	0.000	0.994	0.006
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.994	0.006
Y54.5 Other diuretics	0.000	0.994	0.006
Y48 Anaesthetics and therapeutic gases	0.000	0.994	0.006
Y40.4 Tetracyclines	0.000	0.994	0.006
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.994	0.006
Y57 Other and unspecified drugs and medicaments	0.000	0.994	0.006
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.994	0.006
L50.6 Contact urticaria	0.000	0.994	0.006
L50.5 Cholinergic urticaria	0.000	0.994	0.006
L50.4 Vibratory urticaria	0.000	0.994	0.006
L50.3 Dermatographic urticaria	0.000	0.994	0.006
L50.2 Urticaria due to cold and heat	0.000	0.994	0.006
Y57.9 Drug or medicament, unspecified	0.000	0.994	0.006
L50.1 Idiopathic urticaria	0.000	0.994	0.006
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.994	0.006
Y46.2 Hydantoin derivatives	0.000	0.994	0.006
L71.8 Other rosacea	0.006	0.994	0.000
Y40.6 Rifamycins	0.000	0.994	0.006
L71.0 Perioral dermatitis	0.006	0.994	0.000
Y54.9 Mineral salts, not elsewhere classified	0.000	0.994	0.006
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.994	0.006
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.994	0.006
Y54.0 Mineralocorticoids	0.000	0.994	0.006
Y40.2 Chloramphenicol group	0.000	0.994	0.006
Q61.2 Polycystic kidney, adult type	0.000	0.994	0.006
L51 Erythema multiforme	0.000	0.994	0.006
Y45.5 4-Aminophenol derivatives	0.000	0.994	0.006
L50.8 Other urticaria	0.000	0.994	0.006
Y52.7 Peripheral vasodilators	0.000	0.994	0.006
Y40.7 Antifungal antibiotics, systemically used	0.000	0.994	0.006
Q61 Cystic kidney disease	0.000	0.994	0.006
L53 Other erythematous conditions	0.000	0.994	0.006
Y50 Central nervous system stimulants, not elsewhere classified	0.000	0.994	0.006
L52 Erythema nodosum	0.000	0.994	0.006
Y48.2 Other and unspecified general anaesthetics	0.000	0.994	0.006
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.994	0.005
Y58 Bacterial vaccines	0.000	0.994	0.005
Y47 Sedatives, hypnotics and antianxiety drugs	0.000	0.994	0.005
Y56.3 Emollients, demulcents and protectants	0.000	0.995	0.005
Y53 Agents primarily affecting the gastro-intestinal system	0.000	0.995	0.005
L53.0 Toxic erythema	0.000	0.995	0.005
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.995	0.005
J93 Pneumothorax	0.000	0.995	0.005
L51.9 Erythema multiforme, unspecified	0.000	0.995	0.005
Y56.9 Topical agent, unspecified	0.000	0.995	0.005
Y56.8 Other topical agents	0.000	0.995	0.005
Y56.7 Dental drugs, topically applied	0.000	0.995	0.005
Y56.6 Otorhinolaryngological drugs and preparations	0.000	0.995	0.005
Y56.5 Ophthalmological drugs and preparations	0.000	0.995	0.005
Y56.2 Local astringents and local detergents	0.000	0.995	0.005
Y56.1 Antipruritics	0.000	0.995	0.005
Y51 Drugs primarily affecting the autonomic nervous system	0.000	0.995	0.005
C81.9 Hodgkin's disease, unspecified	0.000	0.995	0.005
J93.8 Other pneumothorax	0.000	0.995	0.005
N70.0 Acute salpingitis and oophoritis	0.005	0.995	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.995	0.005
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.000	0.995	0.005
L54 Erythema in diseases classified elsewhere	0.000	0.995	0.005
N36.2 Urethral caruncle	0.005	0.995	0.000
Y49.5 Other antipsychotics and neuroleptics	0.000	0.995	0.005
Y48.3 Local anaesthetics	0.000	0.995	0.005
Y57.6 Other diagnostic agents	0.000	0.995	0.005
Y59 Other and unspecified vaccines and biological substances	0.000	0.995	0.005
K42.9 Umbilical hernia without obstruction or gangrene	0.000	0.995	0.005
L53.8 Other specified erythematous conditions	0.000	0.995	0.005
Y48.5 Therapeutic gases	0.000	0.995	0.005
Y48.1 Parenteral anaesthetics	0.000	0.995	0.005
Y48.0 Inhaled anaesthetics	0.000	0.995	0.005
L51.1 Bullous erythema multiforme	0.000	0.995	0.005
Y54.8 Agents affecting uric acid metabolism	0.000	0.995	0.005
Q61.9 Cystic kidney disease, unspecified	0.000	0.995	0.005
Y46.8 Antispasticity drugs	0.000	0.995	0.004
Y46.6 Other and unspecified antiepileptics	0.000	0.995	0.005
Y46.3 Deoxybarbiturates	0.000	0.995	0.004
Y46.1 Oxazolidinediones	0.000	0.995	0.004
Y46.0 Succinimides	0.000	0.995	0.004
Y57.7 Vitamins, not elsewhere classified	0.000	0.995	0.005
Y57.4 Pharmaceutical excipients	0.000	0.995	0.005
Y57.3 Alcohol deterrents	0.000	0.995	0.005
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.000	0.995	0.005
Y57.1 Lipotropic drugs	0.000	0.995	0.005
Y57.0 Appetite depressants [anorectics]	0.000	0.995	0.005
W21.9 Unspecified place	0.000	0.995	0.005
J43.9 Emphysema, unspecified	0.000	0.995	0.005
Y46.5 Valproic acid	0.000	0.995	0.004
Y50.2 Methylxanthines, not elsewhere classified	0.000	0.995	0.004
Y44 Agents primarily affecting blood constituents	0.000	0.995	0.005
Y46.7 Anti-Parkinsonism drugs	0.000	0.995	0.004
Z89.5 Acquired absence of leg at or below knee	0.005	0.995	0.000
C81.1 Nodular sclerosis	0.000	0.995	0.005
Y48.4 Anaesthetic, unspecified	0.000	0.995	0.004
C81 Hodgkin's disease	0.000	0.995	0.005
L51.8 Other erythema multiforme	0.000	0.996	0.004
L51.2 Toxic epidermal necrolysis [Lyell]	0.000	0.996	0.004
L51.0 Nonbullous erythema multiforme	0.000	0.996	0.004
Q61.4 Renal dysplasia	0.000	0.996	0.004
Y53.4 Other laxatives	0.000	0.996	0.004
Q61.8 Other cystic kidney diseases	0.000	0.996	0.004
Q61.1 Polycystic kidney, infantile type	0.000	0.996	0.004
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.996	0.004
L53.3 Other chronic figurate erythema	0.000	0.996	0.004
L53.2 Erythema marginatum	0.000	0.996	0.004
L53.1 Erythema annulare centrifugum	0.000	0.996	0.004
Y50.9 Central nervous system stimulant, unspecified	0.000	0.996	0.004
Y50.8 Other central nervous system stimulants	0.000	0.996	0.004
Y50.1 Opioid receptor antagonists	0.000	0.996	0.004
Y50.0 Analeptics	0.000	0.996	0.004
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.000	0.996	0.004
Y55.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.004
Q61.5 Medullary cystic kidney	0.000	0.996	0.004
Y44.5 Thrombolytic drugs	0.000	0.996	0.004
D06.9 Cervix, unspecified	0.000	0.996	0.004
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.996	0.004
Y55.0 Oxytocic drugs	0.000	0.996	0.004
Y58.9 Other and unspecified bacterial vaccines	0.000	0.996	0.004
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.000	0.996	0.004
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.000	0.996	0.004
Y58.5 Diphtheria vaccine	0.000	0.996	0.004
Y58.4 Tetanus vaccine	0.000	0.996	0.004
Y58.3 Plague vaccine	0.000	0.996	0.004
Y58.2 Cholera vaccine	0.000	0.996	0.004
Y58.1 Typhoid and paratyphoid vaccine	0.000	0.996	0.004
Y58.0 BCG vaccine	0.000	0.996	0.004
N10 Acute tubulo-interstitial nephritis	0.000	0.996	0.004
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.000	0.996	0.004
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.000	0.996	0.004
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.000	0.996	0.004
Y47.4 Bromine compounds	0.000	0.996	0.004
Y47.3 Paraldehyde	0.000	0.996	0.004
Y47.2 Chloral derivatives	0.000	0.996	0.004
Y47.0 Barbiturates, not elsewhere classified	0.000	0.996	0.004
Y47.1 Benzodiazepines	0.000	0.996	0.004
K29.3 Chronic superficial gastritis	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.996	0.004
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.996	0.004
Y53.7 Emetics	0.000	0.996	0.004
Y53.6 Antidiarrhoeal drugs	0.000	0.996	0.004
Y53.5 Digestants	0.000	0.996	0.004
Y53.0 Histamine H2-receptor antagonists	0.000	0.996	0.004
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.004
Y55.5 Anticommon cold drugs	0.000	0.996	0.004
Y55.3 Antitussives	0.000	0.996	0.004
Y55.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.004
Y57.5 X-ray contrast media	0.000	0.996	0.004
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
Y53.2 Stimulant laxatives	0.000	0.996	0.004
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.004
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.004
Y51.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.004
Y51.0 Anticholinesterase agents	0.000	0.996	0.004
Y52.1 Calcium-channel blockers	0.000	0.996	0.004
Y49.9 Psychotropic drug, unspecified	0.000	0.996	0.004
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
Y49.7 Psychostimulants with abuse potential	0.000	0.996	0.004
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.996	0.004
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.996	0.004
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.996	0.004
Y41 Other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
Y53.1 Other antacids and anti-gastric-secretion drugs	0.000	0.996	0.004
A08 Viral and other specified intestinal infections	0.000	0.996	0.004
C81.7 Other Hodgkin's disease	0.000	0.996	0.004
Y45.4 Antirheumatics	0.000	0.996	0.004
C81.0 Lymphocytic predominance	0.000	0.996	0.004
J32.8 Other chronic sinusitis	0.000	0.996	0.004
L54.8 Erythema in other diseases classified elsewhere	0.000	0.996	0.004
L54.0 Erythema marginatum in acute rheumatic fever	0.000	0.996	0.004
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.996	0.004
Y55.4 Expectorants	0.000	0.996	0.004
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.003
Y59.9 Vaccine or biological substance, unspecified	0.000	0.996	0.004
Y59.8 Other specified vaccines and biological substances	0.000	0.996	0.004
Y59.2 Protozoal vaccines	0.000	0.996	0.004
Y59.1 Rickettsial vaccines	0.000	0.996	0.004
Y45.0 Opioids and related analgesics	0.000	0.996	0.004
Y53.3 Saline and osmotic laxatives	0.000	0.996	0.003
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.000	0.996	0.003
C81.2 Mixed cellularity	0.000	0.996	0.004
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.996	0.003
J93.1 Other spontaneous pneumothorax	0.000	0.996	0.004
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.996	0.003
Y44.7 Plasma substitutes	0.000	0.996	0.003
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.996	0.003
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.996	0.003
C81.3 Lymphocytic depletion	0.000	0.996	0.003
Y45.8 Other analgesics and antipyretics	0.000	0.996	0.003
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.996	0.003
L53.9 Erythematous condition, unspecified	0.000	0.997	0.003
Y44.6 Natural blood and blood products	0.000	0.997	0.003
Y59.3 Immunoglobulin	0.000	0.997	0.003
Y59.0 Viral vaccines	0.000	0.997	0.003
Y57.8 Other drugs and medicaments	0.000	0.997	0.003
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
Y46.4 Iminostilbenes	0.000	0.997	0.003
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
Y43 Primarily systemic agents	0.000	0.997	0.003
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
R33 Retention of urine	0.003	0.997	0.000
J93.0 Spontaneous tension pneumothorax	0.000	0.997	0.003
Y49.2 Other and unspecified antidepressants	0.000	0.997	0.003
S01.1 Open wound of eyelid and periocular area	0.000	0.997	0.003
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.997	0.003
Z89 Acquired absence of limb	0.003	0.997	0.000
M25.53 Pain in joint (Forearm)	0.003	0.997	0.000
Z89.4 Acquired absence of foot and ankle	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
Y41.4 Anthelminthics	0.000	0.997	0.003
Y41.3 Other antiprotozoal drugs	0.000	0.997	0.003
A08.2 Adenoviral enteritis	0.000	0.997	0.003
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.997	0.003
Z49.1 Extracorporeal dialysis	0.000	0.997	0.003
Y45.2 Propionic acid derivatives	0.000	0.997	0.003
Y40.8 Other systemic antibiotics	0.000	0.997	0.003
A08.0 Rotaviral enteritis	0.000	0.997	0.003
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
Y41.5 Antiviral drugs	0.000	0.997	0.003
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.003	0.997	0.000
Z89.6 Acquired absence of leg above knee	0.003	0.997	0.000
A08.5 Other specified intestinal infections	0.000	0.997	0.003
Y43.1 Antineoplastic antimetabolites	0.000	0.997	0.003
S02.20 Fracture of nasal bones (closed)	0.000	0.997	0.003
B00.4 Herpesviral encephalitis	0.003	0.997	0.000
Y44.2 Anticoagulants	0.000	0.997	0.003
B07 Viral warts	0.003	0.997	0.000
C76.1 Thorax	0.000	0.997	0.003
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.003	0.997	0.000
Z89.9 Acquired absence of limb, unspecified	0.003	0.997	0.000
Z89.2 Acquired absence of upper limb above wrist	0.003	0.997	0.000
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]	0.003	0.997	0.000
A08.3 Other viral enteritis	0.000	0.997	0.002
Y43.2 Antineoplastic natural products	0.000	0.997	0.003
B00 Herpesviral [herpes simplex] infections	0.003	0.997	0.000
G54.9 Nerve root and plexus disorder, unspecified	0.003	0.997	0.000
G54.0 Brachial plexus disorders	0.003	0.997	0.000
G54 Nerve root and plexus disorders	0.003	0.997	0.000
Y43.9 Primarily systemic agent, unspecified	0.000	0.997	0.002
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.997	0.002
Y43.6 Enzymes, not elsewhere classified	0.000	0.997	0.002
Y43.5 Acidifying and alkalising agents	0.000	0.997	0.002
B00.8 Other forms of herpesviral infection	0.003	0.997	0.000
G54.5 Neuralgic amyotrophy	0.003	0.997	0.000
Y41.0 Sulphonamides	0.000	0.997	0.002
Y45.1 Salicylates	0.000	0.997	0.002
Z89.3 Acquired absence of both upper limbs [any level]	0.002	0.997	0.000
Z89.1 Acquired absence of hand and wrist	0.002	0.997	0.000
Q61.0 Congenital single renal cyst	0.000	0.997	0.002
Y40.0 Penicillins	0.002	0.997	0.001
G54.8 Other nerve root and plexus disorders	0.002	0.997	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.002	0.997	0.000
M22.4 Chondromalacia patellae	0.000	0.997	0.003
G54.6 Phantom limb syndrome with pain	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.001	0.998	0.002
B00.1 Herpesviral vesicular dermatitis	0.002	0.998	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.000	0.998	0.002
K26.3 Acute without haemorrhage or perforation	0.002	0.998	0.000
Z89.8 Acquired absence of upper and lower limbs [any level]	0.002	0.998	0.000
B00.0 Eczema herpeticum	0.002	0.998	0.000
G54.1 Lumbosacral plexus disorders	0.002	0.998	0.000
R85.7 Abnormal histological findings	0.000	0.998	0.002
Y43.4 Immunosuppressive agents	0.000	0.998	0.002
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
S02.2 Fracture of nasal bones	0.000	0.998	0.002
B00.7 Disseminated herpesviral disease	0.002	0.998	0.000
B00.3 Herpesviral meningitis	0.002	0.998	0.000
G54.2 Cervical root disorders, not elsewhere classified	0.002	0.998	0.000
M80.88 Other osteoporosis with pathological fracture (Other)	0.000	0.998	0.002
G54.7 Phantom limb syndrome without pain	0.002	0.998	0.000
G54.3 Thoracic root disorders, not elsewhere classified	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
C53.9 Cervix uteri, unspecified	0.002	0.998	0.000
N88.2 Stricture and stenosis of cervix uteri	0.002	0.998	0.000
C70.0 Cerebral meninges	0.000	0.998	0.002
N36 Other disorders of urethra	0.002	0.998	0.000
M80.81 Other osteoporosis with pathological fracture (Shoulder region)	0.000	0.998	0.002
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
N36.3 Prolapsed urethral mucosa	0.002	0.998	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.002	0.998	0.000
E83.1 Disorders of iron metabolism	0.002	0.998	0.000
M80.8 Other osteoporosis with pathological fracture	0.000	0.998	0.002
S02.30 Fracture of orbital floor (closed)	0.000	0.998	0.002
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.998	0.002
N36.0 Urethral fistula	0.002	0.998	0.000
N85.4 Malposition of uterus	0.002	0.998	0.000
S02.21 Fracture of nasal bones (open)	0.000	0.998	0.002
G54.4 Lumbosacral root disorders, not elsewhere classified	0.002	0.998	0.000
M80.1 Postoophorectomy osteoporosis with pathological fracture	0.000	0.998	0.002
N36.1 Urethral diverticulum	0.002	0.998	0.000
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.998	0.002
Z89.0 Acquired absence of finger(s) [including thumb], unilateral	0.002	0.998	0.000
B00.9 Herpesviral infection, unspecified	0.002	0.998	0.000
A87.9 Viral meningitis, unspecified	0.002	0.998	0.000
S02.3 Fracture of orbital floor	0.000	0.998	0.002
W21 Striking against or struck by sports equipment	0.000	0.998	0.002
S02.50 Fracture of tooth (closed)	0.000	0.998	0.002
A08.1 Acute gastro-enteropathy due to Norwalk agent	0.000	0.998	0.001
J35.0 Chronic tonsillitis	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg	0.002	0.998	0.000
M13.98 Arthritis, unspecified (Other)	0.000	0.998	0.002
G11.9 Hereditary ataxia, unspecified	0.002	0.998	0.000
B06 Rubella [German measles]	0.002	0.998	0.000
B05 Measles	0.002	0.998	0.000
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.002	0.998	0.000
B04 Monkeypox	0.002	0.998	0.000
B03 Smallpox	0.002	0.998	0.000
M80.89 Other osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.002
M80.87 Other osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.002
M80.86 Other osteoporosis with pathological fracture (Lower leg)	0.000	0.998	0.002
M80.85 Other osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.002
M80.84 Other osteoporosis with pathological fracture (Hand)	0.000	0.998	0.002
M80.83 Other osteoporosis with pathological fracture (Forearm)	0.000	0.998	0.002
M80.82 Other osteoporosis with pathological fracture (Upper arm)	0.000	0.998	0.002
M80.80 Other osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
N36.9 Urethral disorder, unspecified	0.002	0.998	0.000
S02.7 Multiple fractures involving skull and facial bones	0.000	0.998	0.002
B01 Varicella [chickenpox]	0.002	0.998	0.000
B00.5 Herpesviral ocular disease	0.001	0.998	0.000
M35.0 Sicca syndrome [Sjogren]	0.000	0.998	0.002
M47.89 Other spondylosis (Site unspecified)	0.000	0.998	0.002
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.998	0.001
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.002	0.998	0.000
S02.5 Fracture of tooth	0.000	0.998	0.002
D06 Carcinoma in situ of cervix uteri	0.000	0.998	0.002
B02 Zoster [herpes zoster]	0.002	0.998	0.000
N20 Calculus of kidney and ureter	0.000	0.998	0.002
M76.67 Achilles tendinitis (Ankle and foot)	0.002	0.998	0.000
M80.19 Postoophorectomy osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.001
M80.18 Postoophorectomy osteoporosis with pathological fracture (Other)	0.000	0.998	0.001
M80.17 Postoophorectomy osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.001
M80.16 Postoophorectomy osteoporosis with pathological fracture (Lower leg)	0.000	0.998	0.001
M80.15 Postoophorectomy osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.001
M80.14 Postoophorectomy osteoporosis with pathological fracture (Hand)	0.000	0.998	0.001
M80.13 Postoophorectomy osteoporosis with pathological fracture (Forearm)	0.000	0.998	0.001
M80.12 Postoophorectomy osteoporosis with pathological fracture (Upper arm)	0.000	0.998	0.001
M80.11 Postoophorectomy osteoporosis with pathological fracture (Shoulder region)	0.000	0.998	0.001
M80.9 Unspecified osteoporosis with pathological fracture	0.000	0.998	0.002
S02 Fracture of skull and facial bones	0.000	0.998	0.002
G93.1 Anoxic brain damage, not elsewhere classified	0.002	0.998	0.000
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.002	0.998	0.000
M94.96 Disorder of cartilage, unspecified (Lower leg)	0.000	0.998	0.002
S02.31 Fracture of orbital floor (open)	0.000	0.998	0.001
B02.3 Zoster ocular disease	0.002	0.998	0.000
W21.3 Sports and athletics area	0.000	0.998	0.001
W21.7 Farm	0.000	0.998	0.001
W21.6 Industrial and construction area	0.000	0.998	0.001
W21.5 Trade and service area	0.000	0.998	0.001
W21.4 Street and highway	0.000	0.998	0.001
W21.2 School, other institution and public administrative area	0.000	0.998	0.001
W21.1 Residential institution	0.000	0.998	0.001
W21.0 Home	0.000	0.998	0.001
M80 Osteoporosis with pathological fracture	0.000	0.998	0.002
E78.4 Other hyperlipidaemia	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
M10.96 Gout, unspecified (Lower leg)	0.002	0.998	0.000
S36.10 Injury of liver or gallbladder (without open wound into cavity)	0.001	0.998	0.000
B02.9 Zoster without complication	0.002	0.998	0.000
B05.9 Measles without complication	0.001	0.998	0.000
B05.8 Measles with other complications	0.001	0.998	0.000
B05.4 Measles with intestinal complications	0.001	0.998	0.000
B05.3 Measles complicated by otitis media	0.001	0.998	0.000
B05.2 Measles complicated by pneumonia	0.001	0.998	0.000
B05.1 Measles complicated by meningitis	0.001	0.998	0.000
B05.0 Measles complicated by encephalitis	0.001	0.998	0.000
B06.9 Rubella without complication	0.001	0.998	0.000
B06.8 Rubella with other complications	0.001	0.998	0.000
B06.0 Rubella with neurological complications	0.001	0.998	0.000
E61.1 Iron deficiency	0.000	0.998	0.002
N76.0 Acute vaginitis	0.000	0.998	0.002
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.998	0.001
B01.8 Varicella with other complications	0.001	0.998	0.000
C71.2 Temporal lobe	0.000	0.998	0.002
L12.0 Bullous pemphigoid	0.000	0.998	0.001
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.001	0.998	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.000	0.998	0.001
Q60-Q64 Congenital malformations of the urinary system	0.000	0.998	0.001
B01.9 Varicella without complications	0.001	0.998	0.000
B01.1 Varicella encephalitis	0.001	0.998	0.000
L12.1 Cicatricial pemphigoid	0.000	0.998	0.001
T46.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.998	0.000
W10.8 Other specified place	0.001	0.998	0.000
A87 Viral meningitis	0.001	0.998	0.000
M76.66 Achilles tendinitis (Lower leg)	0.001	0.999	0.000
S02.51 Fracture of tooth (open)	0.000	0.999	0.001
D06.7 Other parts of cervix	0.000	0.999	0.001
N20.9 Urinary calculus, unspecified	0.000	0.999	0.001
Y42.0 Glucocorticoids and synthetic analogs	0.000	0.999	0.001
K42 Umbilical hernia	0.000	0.999	0.001
B01.2 Varicella pneumonia	0.001	0.999	0.000
B01.0 Varicella meningitis	0.001	0.999	0.000
B02.7 Disseminated zoster	0.001	0.999	0.000
B02.0 Zoster encephalitis	0.001	0.999	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.001	0.999	0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.000	0.999	0.001
S36.00 Injury of spleen (without open wound into cavity)	0.001	0.999	0.000
B02.1 Zoster meningitis	0.001	0.999	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.000	0.999	0.001
M54.37 Sciatica (Lumbosacral region)	0.001	0.999	0.000
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.000	0.999	0.001
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.000	0.999	0.001
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.000	0.999	0.001
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.000	0.999	0.001
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.000	0.999	0.001
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.000	0.999	0.001
C76.2 Abdomen	0.000	0.999	0.001
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.000	0.999	0.001
W21.8 Other specified place	0.000	0.999	0.001
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.001	0.999	0.000
J43 Emphysema	0.000	0.999	0.001
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.001	0.999	0.000
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.999	0.001
B02.8 Zoster with other complications	0.001	0.999	0.000
B44.1 Other pulmonary aspergillosis	0.001	0.999	0.000
D06.0 Endocervix	0.000	0.999	0.001
T38.1 Thyroid hormones and substitutes	0.000	0.999	0.001
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.999	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.999	0.001
W21.30 Striking against or struck by sports equipment; Sports and athletics area;While engaged in sports activity	0.000	0.999	0.001
A87.2 Lymphocytic choriomeningitis	0.001	0.999	0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.001	0.999	0.000
L11.1 Transient acantholytic dermatosis [Grover]	0.000	0.999	0.001
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.999	0.001
A87.0 Enteroviral meningitis	0.001	0.999	0.000
F43.1 Posttraumatic stress disorder	0.000	0.999	0.001
M80.4 Drug-induced osteoporosis with pathological fracture	0.000	0.999	0.001
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture	0.000	0.999	0.001
M80.2 Osteoporosis of disuse with pathological fracture	0.000	0.999	0.001
D06.1 Exocervix	0.000	0.999	0.001
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.001	0.999	0.000
L11.0 Acquired keratosis follicularis	0.000	0.999	0.001
M80.5 Idiopathic osteoporosis with pathological fracture	0.000	0.999	0.001
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.000	0.999	0.001
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.000	0.999	0.001
H21.5 Other adhesions and disruptions of iris and ciliary body	0.000	0.999	0.001
K35.3 Acute appendicitis with localized peritonitis	0.001	0.999	0.000
Q63.0 Accessory kidney	0.000	0.999	0.001
T46 Poisoning by agents primarily affecting the cardiovascular system	0.001	0.999	0.000
A81.0 Creutzfeldt-Jakob disease	0.001	0.999	0.000
A87.8 Other viral meningitis	0.001	0.999	0.000
A87.1 Adenoviral meningitis	0.001	0.999	0.000
K42.1 Umbilical hernia with gangrene	0.000	0.999	0.001
N88.3 Incompetence of cervix uteri	0.001	0.999	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.001	0.999	0.000
L12 Pemphigoid	0.000	0.999	0.001
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.000	0.999	0.001
C76.8 Overlapping lesion of other and ill-defined sites	0.000	0.999	0.001
C76.7 Other ill-defined sites	0.000	0.999	0.001
C76.5 Lower limb	0.000	0.999	0.001
C76.4 Upper limb	0.000	0.999	0.001
C76.3 Pelvis	0.000	0.999	0.001
Q63 Other congenital malformations of kidney	0.000	0.999	0.001
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.001	0.999	0.000
B08.5 Enteroviral vesicular pharyngitis	0.001	0.999	0.000
B08.4 Enteroviral vesicular stomatitis with exanthem	0.001	0.999	0.000
B08.3 Erythema infectiosum [fifth disease]	0.001	0.999	0.000
B08.2 Exanthema subitum [sixth disease]	0.001	0.999	0.000
B08.0 Other orthopoxvirus infections	0.001	0.999	0.000
J43.1 Panlobular emphysema	0.000	0.999	0.001
J43.0 MacLeod's syndrome	0.000	0.999	0.001
Q62.3 Other obstructive defects of renal pelvis and ureter	0.000	0.999	0.001
Q62.1 Atresia and stenosis of ureter	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations